Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000034106 | SCV004195216 | pathogenic | Somatotroph adenoma | 2023-10-27 | criteria provided, single submitter | clinical testing | |
Invitae | RCV003555922 | SCV004294891 | pathogenic | not provided | 2023-12-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr268*) in the AIP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 63 amino acid(s) of the AIP protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with pituitary adenoma (PMID: 17341560). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4892). This variant disrupts a region of the AIP protein in which other variant(s) (p.Arg271Trp) have been determined to be pathogenic (PMID: 17244780, 19684062, 21753072, 26186299). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000005170 | SCV000025347 | pathogenic | Pituitary adenoma predisposition | 2007-05-01 | no assertion criteria provided | literature only | |
Gene |
RCV000034106 | SCV000058036 | probable-pathogenic | Somatotroph adenoma | 2012-06-21 | no assertion criteria provided | curation | Converted during submission to Likely pathogenic. |